Xenex Disinfection Services is a company that provides an innovative UV disinfection technology to healthcare facilities. It manufactures a robot called LightStrike that utilizes intense bursts of broad spectrum, pulsed xenon UV light to destroy pathogens on surfaces. The LightStrike technology is effective against various harmful microorganisms, including multi-drug resistant organisms like methicillin-resistant Staphylococcus aureus (MRSA), Clostridioides difficile (C. diff), vancomycin-resistant Enterococci (VRE), and even SARS-CoV-2, the virus that causes Covid-19.
The LightStrike robots are designed to enhance the manual cleaning process by eliminating pathogens missed during routine cleaning, providing an additional layer of disinfection. As of October 2022, LightStrike robots deployed by Xenex's customers had completed over 35 million disinfection cycles worldwide. The technology has been validated by more than 45 peer-reviewed studies published in scientific journals, and its efficacy is protected by 193 patents.
In February 2023, Xenex filed a De Novo petition with the US Food and Drug Administration (FDA) seeking medical device market authorization for its LightStrike+ technology. This move aims to strengthen the company's position in the UV disinfection industry and provide hospitals with clarity when selecting UV disinfection solutions.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.